Drug survival rate of dupilumab in Japanese patients with atopic dermatitis
Enregistré dans:
Auteurs principaux: | Susumu Ichiyama, Michiko Ito, Toshihiko Hoashi, Naoko Kanda, Hidehisa Saeki |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cd67de0ed1314b13b2e1e62003fb6184 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis
par: Jonathan I. Silverberg, et autres
Publié: (2021) -
Identification of Keratinocyte Mitogens: Implications for Hyperproliferation in Psoriasis and Atopic Dermatitis
par: Hanna Niehues, et autres
Publié: (2022) -
Update: Can breastfeeding and maternal diet prevent atopic dermatitis?
par: Colleen Little, et autres
Publié: (2017) -
Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report
par: Hideaki Uchida, et autres
Publié: (2021) -
Emerging Roles of Adipose Tissue in the Pathogenesis of Psoriasis and Atopic Dermatitis in Obesity
par: Zhuolin Guo, et autres
Publié: (2022)